Search results
Showing 1951 to 1965 of 9090 results
In development Reference number: GID-QS10188 Expected publication date: TBC
Etrolizumab for treating moderately to severely active ulcerative colitis [ID3827]
Awaiting development Reference number: GID-TA10717 Expected publication date: TBC
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]
In development Reference number: GID-TA11036 Expected publication date: TBC
Laroprovstat for treating primary hypercholesterolaemia or mixed dyslipidaemia disease
Awaiting development Reference number: GID-TA12477 Expected publication date: TBC
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]
In development Reference number: GID-TA11501 Expected publication date: TBC
Suspected sepsis in pregnancy: recognition, diagnosis and early management
In development Reference number: GID-NG10468 Expected publication date: 17 March 2027
Suspected sepsis in under 16s: recognition, diagnosis and early management
In development Reference number: GID-NG10466 Expected publication date: 17 March 2027
Radiofrequency ablation of the basivertebral nerve for chronic low back pain
Awaiting development Reference number: GID-HTG10871 Expected publication date: TBC
Awaiting development Reference number: GID-HTG10872 Expected publication date: TBC
In development Reference number: GID-QS10200 Expected publication date: 24 March 2027
In development Reference number: GID-TA11963 Expected publication date: 13 January 2027
In development Reference number: GID-TA11766 Expected publication date: TBC
Awaiting development Reference number: GID-HTG10873 Expected publication date: TBC
In development Reference number: GID-NG10457 Expected publication date: TBC
Lenacapavir for preventing HIV-1 in people aged 16 years or older [ID6495]
In development Reference number: GID-TA11638 Expected publication date: TBC